Meiji Yasuda Life Insurance Company »

Neurocrine Biosciences shares owned by Meiji Yasuda Life Insurance Company

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Meiji Yasuda Life Insurance Company from 13F filings

Historical chart of Meiji Yasuda Life Insurance Company investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Meiji Yasuda Life Insurance Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Meiji Yasuda Life Insurance Company

Quarter filed Position value Share count Share price at filing
2024-06-30 $799k 5.8k 137.67
2024-03-31 $455k 3.3k 137.92

More positions owned by Meiji Yasuda Life Insurance Company

Ishares Tr Iboxx Inv Cp Etf Ishares Tr Iboxx Inv Cp Etf (LQD)
Spdr Ser Tr Prtflo S&p500 Hi Spdr Ser Tr Prtflo S&p500 Hi (SPYD)
Ishares Tr Core S&p500 Etf Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core High Dv Etf Ishares Tr Core High Dv Etf (HDV)
Vanguard Scottsdale Fds Lg-term Cor Bd Vanguard Scottsdale Fds Lg-term Cor Bd (VCLT)
Vanguard Whitehall Fds High Div Yld Vanguard Whitehall Fds High Div Yld (VYM)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Usd Inv Grde Etf Ishares Tr Usd Inv Grde Etf (USIG)
Alphabet Inc Cap Stk CL C (GOOG)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)

View all positions for Meiji Yasuda Life Insurance Company

Top funds holding Neurocrine Biosciences

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Bellevue Group
Geode Capital Management
Citadel Advisors
AQR Capital Management
T. Rowe Price Associates
Morgan Stanley
Jpmorgan Chase & Co
Deerfield Management Company
Dodge & Cox
Goldman Sachs Group

View all funds holding Neurocrine Biosciences